Literature DB >> 12029209

Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumours: effects of insulin and glucose loading.

S Zhao1, Y Kuge, E Tsukamoto, T Mochizuki, T Kato, K Hikosaka, K Nakada, M Hosokawa, M Kohanawa, N Tamaki.   

Abstract

The expression of glucose transporters (GLUTs) and its relationship to fluorodeoxyglucose accumulation in malignant tumours have been well investigated, while such a relation has not been studied in inflammatory lesions. The aim of the present study was to investigate the effects of insulin and glucose loading on the expression of GLUTs in inflammatory lesions and compare them with those in malignant tumours in relation to fluorodeoxyglucose accumulation. All tissue specimens used in this study were obtained in our previous study, in which rats were inoculated with allogenic hepatoma cells (KDH-8), Staphylococcus aureus, or turpentine oil into the left calf muscle and divided into three subgroups: insulin loaded, glucose loaded, and control groups. The expression of glucose transporters (GLUT-1 to GLUT-5) was investigated by immunostaining the lesions (n=5-6, for each group). In all control groups, the expression levels of GLUT-1 and GLUT-3 were significantly higher than those of GLUT-2, GLUT-4 and GLUT-5. Insulin loading did not significantly affect the expression levels of GLUT-1 and GLUT-3 in these lesions except for a significant but slight decrease in the GLUT-1 expression level in the inflammatory lesion of non-infectious origin (89% of the control value). Glucose loading significantly decreased the expression level of GLUT-1 in the inflammatory lesion of non-infectious origin (70% of the control value, P<0.01), and that of GLUT-3 in the inflammatory lesion of infectious origin (70% of the control value, P<0.05), while the expression levels of GLUT-1 and GLUT-3 in the tumour were not significantly affected. These results demonstrate the effects of insulin and glucose loading on the expression level of a molecule (GLUT proteins). The decreased GLUT-1 and GLUT-3 expression levels induced by glucose loading may partly explain the impaired FDG uptake observed in our previous study.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12029209     DOI: 10.1097/00006231-200206000-00006

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  13 in total

Review 1.  What nuclear cardiology can learn from nuclear oncology.

Authors:  Ismet Sarikaya; Steven M Larson; Alvin Freiman; H William Strauss
Journal:  J Nucl Cardiol       Date:  2003 May-Jun       Impact factor: 5.952

Review 2.  Functional imaging of infection: conventional nuclear medicine agents and the expanding role of 18-F-FDG PET.

Authors:  Marguerite T Parisi
Journal:  Pediatr Radiol       Date:  2011-05-24

3.  Fluorine-18 Fluorodeoxyglucose Uptake in Hepatocellular Carcinoma: Correlation with Glucose Transporters and p53 Expression.

Authors:  Ana F Brito; Ana M Abrantes; Marina Ribeiro; Rui Oliveira; João Casalta-Lopes; Ana C Gonçalves; Ana B Sarmento-Ribeiro; José G Tralhão; Maria F Botelho
Journal:  J Clin Exp Hepatol       Date:  2015-06-03

4.  Impact of Plasma Glucose Level at the Time of Fluorodeoxyglucose Administration on the Accuracy of FDG-PET/CT in the Diagnosis of Pancreatic Lesions.

Authors:  Alireza Hamidian Jahromi; Mohammad Kazem Fallahzadeh; Amol Takalkar; Jean Sheng; Gazi Zibari; Hosein Shokouh Amiri
Journal:  Int J Endocrinol Metab       Date:  2014-10-01

5.  Expression of Glut-1 and HK-II in Pancreatic Cancer and Their Impact on Prognosis and FDG Accumulation.

Authors:  Hai-Jing Yang; Wei-Jia Xu; Yi-Hui Guan; Hui-Wei Zhang; Wei-Qun Ding; Lan Rong; Zhi-Bing Qiu; Liang Zhong
Journal:  Transl Oncol       Date:  2016-12       Impact factor: 4.243

6.  Diagnostic accuracy of 18F-FDG-PET in abdominal sepsis in rats.

Authors:  Ítalo Medeiros Azevedo; Robson Macedo Filho; Keyla Borges Ferreira Rocha; Cláudia Nunes Oliveira; Aldo Cunha Medeiros
Journal:  Acta Cir Bras       Date:  2020-06-22       Impact factor: 1.388

Review 7.  FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.

Authors:  Kumi Ozaki; Kenichi Harada; Noboru Terayama; Nobuyuki Kosaka; Hirohiko Kimura; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2020-04-03       Impact factor: 2.374

8.  Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels.

Authors:  Jan Bucerius; Venkatesh Mani; Colin Moncrieff; Josef Machac; Valentin Fuster; Michael E Farkouh; Ahmed Tawakol; James H F Rudd; Zahi A Fayad
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-23       Impact factor: 9.236

9.  [18F]2-fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil.

Authors:  S A Suttie; K G M Park; T A D Smith
Journal:  Br J Cancer       Date:  2007-09-11       Impact factor: 7.640

10.  Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis.

Authors:  Jan Bucerius; Fabien Hyafil; Hein J Verberne; Riemer H J A Slart; Oliver Lindner; Roberto Sciagra; Denis Agostini; Christopher Übleis; Alessia Gimelli; Marcus Hacker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-17       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.